Biologically treated wastewater spiked with a mixture of 56 active pharmaceutical ingredients (APIs) was treated with 0-20 mg/L chlorine dioxide (ClO 2 ) solution in laboratory-scale experiments. Wastewater effluents were collected from two wastewater treatment plants in Sweden, one with extended nitrogen removal (low COD) and one without (high COD). About one third of the tested APIs resisted degradation even at the highest ClO 2 dose (20 mg/L), while others were reduced by more than 90% at the lowest ClO 2 level (0.5 mg/L). In the low COD effluent, more than half of the APIs were oxidized at 5 mg/L ClO 2 , while in high COD effluent a significant increase in API oxidation was observed after treatment with 8 mg/L ClO 2 .
Introduction
One of the pressing problems in wastewater treatment plants (WWTPs) is the inability of conventional methods to completely remove active pharmaceutical ingredients (APIs) due to their high resistance to biodegradation and/or limited biological activity, especially in cold climates such as that in Sweden [1, 2] . The extensive usage and hence release of traces of many pharmaceuticals in wastewater effluents may lead to surface and groundwater contamination compromising the aquatic ecosystem and the environment [3, 4] .
Where biological treatment is not sufficient, improvement in WWTPs can be achieved by an additional chemical oxidation step to remove potential pollutants that cannot be degraded biologically [5, 6, 7, 8] . Among the chemical oxidants applied in water treatment reported in the literature, chlorine dioxide is one that merits further investigation regarding its potential to remove APIs in wastewater. As in the case of ozonation, the application of chlorine dioxide to treat drinking water, surface water and wastewater effluents has shown promising results for the removal of pharmaceuticals. The non-steroidal anti-inflammatory drug diclofenac, reported as one of the most frequently detected compounds in water at concentrations up to the g/L level [9] , is among the pharmaceuticals completely degraded during drinking 3 and surface water treatment at the lowest ClO 2 dose applied [10] . In wastewater effluents, steroid estrogens and industrial estrogenic chemicals, as well as personal care products, were removed by low doses of ClO 2 between 1.25 and 3.75 mg/L, and the removal of estrogenic potency was observed at the same time [11] . The removal of several antibiotics found in water has also demonstrated the ability of ClO 2 as an oxidant [12, 13] .
When ClO 2 was used for selective oxidation of organic micropollutants in other investigations on biologically treated wastewater, it was found that smaller doses, e.g. up to 4 mg/L (depending on the concentrations tested and the matrix) were consumed in less than a minute through reactions with the soluble components in the water, while still completely removing many of the reactive micropollutants. This fast consumption of the oxidant in wastewater has been observed in previous studies by Andersen [11] , Hey et al. [14] , Lee and von Gunten [6] and Andersen et al. [15] .
Based on ClO 2 reactivity in wastewater effluents, it has been suggested that ClO 2 could be used as an alternative to ozone for the removal of micropollutants. It is easy to introduce a ClO 2 dosing step in a WWTP since ClO 2 is produced as a solution in water by mixing aqueous solutions of the reactants in a simple reactor; furthermore, the ClO 2 stock solution is semi-storable. This is much simpler than treatment with ozone, which requires on-site delivery of dry oxygen and considerable electric power to run an expensive and complicated ozone generator which produces an ozone gas mixture with less than 20% ozone yield. Following the generation of ozone, the gas must be transferred to the water using a gas contact reactor, usually with 5-20 min hydraulic retention time [5, 7, 16] .
When ClO 2 is used for oxidation of water with low NOM (natural organic matter), most of the ClO 2 is reduced to chlorite by reactions with the organic matter.
Chlorate is also formed as a by-product, but at a much lower concentration than chlorite [17, 18, 19] . According to Korn [18] and Lee [19] , the formation of chlorite and chlorate accounts for about 70% and 10%, respectively, of the chlorine dioxide applied. In drinking water with low NOM, chlorite reacts slowly with organic matter and is reduced to chloride, while in wastewater, significantly more NOM is available to reduce the chlorite. Toxicity derived from chlorite residuals after treatment may be problematic depending on the concentration and degradation rate [20] . ClO 2 differs from chlorine in that it produces very little chloro-organic by-products [11, 15, 21] . 4 The formation of undesirable by-products can be controlled by minimizing the dose of ClO 2 and applying post-treatment using, for example, ferrous iron (Fe   2+   ) or sulfite   (SO 3   2- ), which reduces ClO 2 and chlorite residuals to chloride [22, 23] . The removal of ClO 2 and chlorite residuals allows higher levels of ClO 2 to be used for treatment providing effective micropollutant removal.
In this study, the removal of 56 different APIs in biologically treated wastewater was investigated in both low-and high-COD effluents using different doses of chlorine dioxide. The APIs were chosen to represent different classes of pharmaceuticals commonly sold and used in Sweden, which will most likely end up in WWTP effluents due to their low sorption to sludge [24] . The effectiveness of the treatment was evaluated by monitoring the oxidant consumption and the amount of APIs oxidized. Oxidation by-products were not evaluated in this study as the aim was to determine the most suitable oxidant dose and identify which APIs can be removed.
Once the relevant dose has been determined, attention can be turned towards investigating the ClO 2 by-products.
Materials and methods

Chemicals
All pharmaceutical reference standards were purchased as solids of analytical grade (>98%) from different suppliers. All APIs investigated are listed in Supplementary Information Table S1 . Methanol and acetonitrile were of LC/MS grade (Merck, Darmstadt, Germany). Ultrapure water was prepared from deionized water using a Milli-Q Gradient system (Millipore, Billerica, MA), equipped with a UV radiation source. A stock solution of APIs was prepared in methanol at concentration of about 100 mg/L. Solutions for spiking and analysis were prepared by precise dilution of the stock solution. Chlorine dioxide was synthesized by adding equal volumes (25 mL each) of 9% HCl (Merck, Darmstadt, Germany) and 7.5% NaClO 2 (Sigma Aldrich, Steinheim, Germany) to 400 mL deionized water. The solution was allowed to react in the dark for at least 10 hours and then diluted to 1000 mL with water. This resulted in an approximately 1 g/L ClO 2 stock solution.
Analytical methods
The concentration of residual ClO 2 was quantified by reaction with DPD (N,Ndiethyl-p-phenylenediamine) using an Allcon spectrophotometer (Alldos GmbH, Germany) with a built-in calibration line for ClO 2 . The analysis of ClO 2 with DPD was performed according to the manufacturer's instructions.
For the analysis of the APIs, samples of 100 mL treated effluent were filtered using a 0.45 m membrane filter (Millipore, Ireland) then acidified to pH 3 using sulfuric acid. Five ng of Table S2 . Maximum difference between results at quantification and qualification mass transition was set to 30% as criterion for positive identification of the analyte. The same method is used by Hörsing et al. [24] and Grabic et al.
(unpublished results) [25] .
Experimental setup
Wastewater effluents
Wastewater effluents were collected after secondary treatment from two WWTPs in southern Sweden. Effluent 1 was collected from Källby WWTP after the activated sludge system which is operated with extended nitrogen removal. Effluent 2 was obtained from Sjölunda WWTP after a high loaded activated sludge process before nitrogen removal. This wastewater is typical of that in many Swedish WWTPs which are operated without nitrogen removal due to their location in the northern part of the country where the climate is colder. Sjölunda also employs full nitrogen removal but using a biofilm system after a highly loaded activated sludge 6 plant. Nitrification is achieved in trickling filters and denitrification in moving bed biofilm reactors with the addition of external carbon. Table 1 
Oxidation experiments
Effluent samples of 150 mL each were prepared in Schott Duran® bottles and spiked with mixed APIs to a final concentration of approx. 1 g/L. ClO 2 was added to duplicate samples at concentrations ranging from 0-20 mg/L. All samples were stored in the dark and allowed to react overnight (approx. 18 h) at room temperature, after which the pH and oxidant concentration in the samples were measured. Residual oxidants were removed by the addition of 50 mg/L sodium sulfite. Table 2 lists the APIs investigated, including information on the class of drug, arranged according to the ease with which they were oxidized by ClO 2 (based on
Results and discussion
Effluent 1).
No further pH adjustments were made during the entire experiment. The pH of the samples did not change significantly after treatment, even with the highest oxidant dose of 20 mg/L, where the sample remained slightly acidic (~pH 6.2-6.5). This slight decrease in pH is expected since the stock solutions of ClO 2 contain some residual HCl from the synthesis. Only few APIs were oxidized by more than 90% at the lowest dose of ClO 2 (0.5 mg/L), while high oxidative degradation was observed with higher doses (8-20 mg/L).
The degree to which each API was oxidized at different ClO 2 doses is shown in Figure   2A and 2B for Effluents 1 and 2, respectively. The vertical lines divide the APIs into easily, moderately, poorly (based on the ClO 2 dose required to achieve 90-100% degradation) and non-oxidizable APIs (less than 90% degradation with 20 mg/L ClO 2 ).
As shown for Effluent 1 ( Figure 2A and Table 2 ), 11 of the APIs from 8 different therapeutic classes could be oxidized by more than 90% with 0.5-1.25 mg/L ClO 2 .
These include all 3 hormones, 2 antibiotics, 1 antihistamine, and 1 narcotic analgesic, as well as the antiplatelet, antidiabetic, antiphlogistic and narcotic antagonist compounds. The common reactive and electron-rich functional groups in these APIs are aniline in diclofenac, phenol in hormones, buprenorphine, and naloxone, and tertiary amines in promethazine, clindamycine, dipyridamole, repaglinide and ciprofloxacin. The high reactivity of ClO 2 with aniline, phenolic and tertiary amine functional groups has been reported in a number of studies [6, 10, 26] . The reactivity of ClO 2 with the piperazine ring of the antibiotic ciprofloxacin has also been reported by Wang et al. [13] . Similarly, Navalon et al. [12] also showed high reactivity of ciprofloxacin with ClO 2 in both surface water and wastewater effluent. [7, 26, 27, 28, 29] . The secondary aminecontaining beta blockers, metoprolol and bisoprolol are also considered less susceptible to ClO 2 oxidation. Lee and von Gunten [6] reported the poor transformation of the beta blocker atenolol which has a secondary amine functional group. However, the oxidizability of the beta blocker sotalol can be explained by the presence of the ClO 2 reactive sulfonamide functional group in its structure. The same 12 degree of API oxidation can be achieved in the high COD effluent (2) as in the low COD effluent (1), but higher ClO 2 doses are required. This is due to consumption of the ClO 2 competitively with the APIs by other organic components in the wastewater [6] . In addition, the presence of inorganic components in the wastewater also consumes some of the oxidant and this could affect the removal of the target micropollutants [6] .
The oxidation, and thus a much higher dose of ClO 2 would be needed for oxidation.
APIs such as diclofenac, sulfamethoxazole and estrogens have been found to be oxidized by more than 90% during ozonation of municipal wastewater effluents at O 3 doses of ≥ 2 mg/L, while a much higher O 3 dose was required for the effective removal of bezafibrate [30] . Ternes et al. [7] also found significant removal (> 90%) of sulfamethoxazole, diclofenac, carbamazepine, and sotalol during treatment of municipal sewage effluent with 5 mg/L O 3 , while a higher O 3 dose of 10-15 mg/L was required to effectively remove the beta blocker metoprolol, which also exhibits low reactivity to ClO 2 . In the present study, ClO 2 was able to oxidize several APIs effectively at doses comparable to those of ozone. The reactivity of carbamazepine was very different since it could be removed by low ozone doses, while it is almost completely resistant to ClO 2 .
The oxidation of APIs by ClO 2 is comparable to oxidation by molecular ozone as both are selective oxidants and are capable of transforming organic micropollutants 13 based on the reactivity of the structure and the characteristics of the water matrix.
These chemical oxidants react with electron-rich functional groups such as phenolic and amino groups, which can be found in the structures of most of the APIs investigated [6, 10, 31, 32, 33] . However, the reaction between ClO 2 and some APIs was much slower than ozonation, even with the same reactive functional group. Therefore, the usefulness of ClO 2 end-of-pipe treatment of WWTP effluents will depend on whether the micropollutants deemed to be critical for the receiving water are sensitive to ClO 2 . Running costs must also be considered since ClO 2 is slightly more expensive to produce than ozone, while it is far simpler and less expensive to build both the generator and reaction chamber for ClO 2 treatment. The treatment perspective then is mainly to use ClO 2 -treatment for small scale WWTP (< 2,000 person equivalent) effluents or where treatment is required only for a limited time.
Two of the APIs investigated here may be of considerable concern regarding the discharge of wastewater effluents into surface water. Both ethinyl estradiol, a pharmaceutical with a high endocrine-disrupting ability [34] , and diclofenac, identified as a contaminant that causes direct toxic effects in the environment [35, 36] , were found to be very sensitive to ClO 2 oxidation. However, if other less reactive
APIs, e.g. bezafibrate or carbamazepine, were found to be of concern regarding aquatic life in the receiving water body of the WWTP effluent, ClO 2 treatment would not be a suitable treatment option.
Conclusions
The results of this study show that ClO 2 can be used to treat wastewater effluents to oxidize various APIs belonging to different therapeutic classes. However, there was considerable variation in the reactivity of the investigated APIs to ClO 2 . The degree of oxidation was found to be dependent on the type of wastewater; API removal is better from the low COD wastewater from the plant with extended nitrogen removal, than the one without (high COD wastewater), at the same oxidant dose. In addition, the reactivity of the APIs depends on the reactive functional group present. APIs with electron-withdrawing functional groups appear to be more resistant to ClO 2 oxidation.
ClO 2 oxidation by-products and toxicity must be investigated before this method can be considered for application in wastewater treatment. The use of ClO 2 oxidation for the removal of pharmaceuticals may be beneficial in small wastewater treatment plants where ozonation could be too expensive and complicated. 
